Buyout Case for Salesforce Feels Real, Benioff Blocks
Salesforce faces a mounting private-equity thesis as cash flow and stock discipline collide with high-profile leaders...
Short term financial aid is available to those in need. Find out where to access assistance and improve your situation.
27,173 articlesSalesforce faces a mounting private-equity thesis as cash flow and stock discipline collide with high-profile leaders...
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
As Shake Shack charts a path into 2025, investors seek clarity on margins, store growth, and digital momentum. This g...
A practical guide to understanding Fuel Tech (FTEK) in 2025. Learn what to watch in Q4 results, identify catalysts, a...
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Gold miners and royalty firms are drawing attention as uncertainty lingers and rates shift. This report breaks down t...
Affirm stock has caught investors' attention as it swings between growth bets and risk concerns. This guide breaks do...
Murphy Oil has surged about 48% in the past year, with shares trading near a 52-week high as Vietnam offshore project...
Tapestry reports a record quarter as Coach powerfully taps Gen Z demand with a Goldilocks mix of luxury and accessibi...
Stocks rose Tuesday as AI momentum outweighed inflation jitters, with fresh analyst calls on Autodesk, Celanese, DexC...
Oil prices cooled modestly on May 14, 2026, with Brent trading around $107.82 per barrel. Analysts say the current pr...
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...